{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:19:39Z","timestamp":1794575979648,"version":"4.9.1"},"reference-count":112,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:p>Vaginitis is defined as inflammation or infection of the vagina and is associated with a spectrum of symptoms, including vulvovaginal itching, burning, irritation, dyspareunia, \u201cfishy\u201d vaginal odor, and abnormal vaginal discharge. Vaginal symptoms are some of the most frequent reasons for patient visits to obstetrician\u2013gynecologists (1) and may have important consequences in terms of discomfort and pain, days lost from school or work, sexual functioning, and self-image (2). Distinguishing vaginal from vulvar symptoms is important to direct evaluation and treatment. The purpose of this document is to provide updated evidence-based guidance for the diagnosis and treatment of the common causes of vaginitis in nonpregnant patients. Information on the treatment of vaginitis in patients with human immunodeficiency virus (HIV) is covered elsewhere (3). Guidelines are subject to change. For the most up-to-date information on vaginitis diagnosis and treatment, see the Centers for Disease Control and Prevention (CDC) Sexually Transmitted Diseases webpage, which is available at https:\/\/www.cdc.gov\/std\/.<\/jats:p>","DOI":"10.1097\/aog.0000000000003604","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T12:37:52Z","timestamp":1576759072000},"page":"e1-e17","source":"Crossref","is-referenced-by-count":95,"title":["Vaginitis in Nonpregnant Patients"],"prefix":"10.1097","volume":"135","member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/jama.291.11.1368","article-title":"Evaluation of vaginal complaints","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12955-016-0470-2","article-title":"Health-related quality of life as measured with the Short-Form 36 (SF-36) questionnaire in patients with recurrent vulvovaginal candidiasis","volume":"14","author":"Zhu","year":"2016","journal-title":"Health Qual Life Outcomes"},{"key":"R3-20230711","first-page":"e89","article-title":"Gynecologic care for women and adolescents with human immunodeficiency virus. Practice Bulletin No. 167. American College of Obstetricians and Gynecologists","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/OLQ.0b013e318074e565","article-title":"The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health","volume":"34","author":"Koumans","year":"2007","journal-title":"Sex Transm Dis"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/AOG.0000000000002460","article-title":"Diagnosis and treatment of vulvar dermatoses","volume":"131","author":"Stockdale","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/AOG.0b013e3182117c9e","article-title":"Prognosis and treatment of desquamative inflammatory vaginitis","volume":"117","author":"Sobel","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/0002-9378(94)90135-X","article-title":"Desquamative inflammatory vaginitis: a new subgroup of purulent vaginitis responsive to topical 2% clindamycin therapy","volume":"171","author":"Sobel","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"R8-20230711","first-page":"124","article-title":"Desquamative inflammatory vaginitis: what is it?","volume":"53","author":"Murphy","year":"2008","journal-title":"J Reprod Med"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/GME.0000000000000329","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Vulvovaginal Atrophy Terminology Consensus Conference Panel","volume":"21","author":"Portman","year":"2014","journal-title":"Menopause"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jpag.2013.05.003","article-title":"Vulvo-vaginitis in prepubertal girls: new ways of administering old drugs","volume":"26","author":"Tartaglia","year":"2013","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jpag.2016.08.002","article-title":"Clinical recommendation: vulvovaginitis","volume":"29","author":"Zuckerman","year":"2016","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.bpobgyn.2014.07.006","article-title":"Recurrent vulvovaginitis","volume":"28","author":"Powell","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R13-20230711","first-page":"765","article-title":"Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina","volume":"100","author":"Ness","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.AOG.0000247627.84791.91","article-title":"Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data","volume":"109","author":"Allsworth","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"suppl 1","key":"R15-20230711","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1073\/pnas.1002611107","article-title":"Vaginal microbiome of reproductive-age women","volume":"108","author":"Ravel","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/infdis\/174.5.1058","article-title":"Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections","volume":"174","author":"Hawes","year":"1996","journal-title":"J Infect Dis"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1086\/592974","article-title":"Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis","volume":"47","author":"Fethers","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1086\/339884","article-title":"Characterization of vaginal flora and bacterial vaginosis in women who have sex with women","volume":"185","author":"Marrazzo","year":"2002","journal-title":"J Infect Dis"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1086\/648092","article-title":"Early sexual experiences and risk factors for bacterial vaginosis","volume":"200","author":"Fethers","year":"2009","journal-title":"J Infect Dis"},{"issue":"RR-03","key":"R20-20230711","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015. Centers for Disease Control and Prevention [published erratum appears in MMWR Recomm Rep. 2015;64:924]","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ajog.2004.05.033","article-title":"Antimicrobial resistance associated with the treatment of bacterial vaginosis","volume":"191","author":"Beigi","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/OLQ.0b013e31827c5a5b","article-title":"Does bacterial vaginosis cause pelvic inflammatory disease?","volume":"40","author":"Taylor","year":"2013","journal-title":"Sex Transm Dis"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1097\/QAD.0000000000000432","article-title":"The vaginal microbiota and susceptibility to HIV","volume":"28","author":"Buve","year":"2014","journal-title":"AIDS"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1086\/657320","article-title":"Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection","volume":"202","author":"Brotman","year":"2010","journal-title":"J Infect Dis"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/OLQ.0b013e318286bb53","article-title":"Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008","volume":"40","author":"Satterwhite","year":"2013","journal-title":"Sex Transm Dis"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1086\/522532","article-title":"The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004","volume":"45","author":"Sutton","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/OLQ.0b013e3181644b9c","article-title":"Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics","volume":"35","author":"Helms","year":"2008","journal-title":"Sex Transm Dis"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"370.e1","DOI":"10.1016\/j.ajog.2007.10.795","article-title":"Management of trichomonas vaginalis in women with suspected metronidazole hypersensitivity","volume":"198","author":"Helms","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R29-20230711","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/LGT.0b013e318273e8cf","article-title":"Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey","volume":"17","author":"Foxman","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"R30-20230711","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1469-0691.2009.02842.x","article-title":"Vaginal and endocervical microorganisms in symptomatic and asymptomatic non-pregnant females: risk factors and rates of occurrence","volume":"15","author":"Tibaldi","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"R31-20230711","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1396-0296.2004.04011.x","article-title":"Vulvar fissures: causes and therapy","volume":"17","author":"Edwards","year":"2004","journal-title":"Dermatol Ther"},{"key":"R32-20230711","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/AOG.0000000000000551","article-title":"Management of persistent vaginitis","volume":"124","author":"Nyirjesy","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R33-20230711","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/jcm.29.2.297-301.1991","article-title":"Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation","volume":"29","author":"Nugent","year":"1991","journal-title":"J Clin Microbiol"},{"key":"R34-20230711","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9343(83)91112-9","article-title":"Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations","volume":"74","author":"Amsel","year":"1983","journal-title":"Am J Med"},{"key":"R35-20230711","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ajog.2004.02.015","article-title":"Predictive value of the clinical diagnosis of lower genital tract infection in women","volume":"190","author":"Landers","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R36-20230711","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.AOG.0000145752.97999.67","article-title":"Evaluation of clinical methods for diagnosing bacterial vaginosis","volume":"105","author":"Gutman","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R37-20230711","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/JCM.43.3.1304-1308.2005","article-title":"Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis","volume":"43","author":"Bradshaw","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R38-20230711","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/JCM.00506-12","article-title":"Development and validation of a semiquantitative, multitarget PCR assay for diagnosis of bacterial vaginosis","volume":"50","author":"Cartwright","year":"2012","journal-title":"J Clin Microbiol"},{"key":"R39-20230711","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/1064744042000210375","article-title":"Clinical evaluation of affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis\/vaginosis","volume":"12","author":"Brown","year":"2004","journal-title":"Infect Dis Obstet Gynecol"},{"key":"R40-20230711","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1128\/JCM.01537-13","article-title":"Comparison of nucleic acid amplification assays with BD affirm VPIII for diagnosis of vaginitis in symptomatic women","volume":"51","author":"Cartwright","year":"2013","journal-title":"J Clin Microbiol"},{"key":"R41-20230711","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/AOG.0000000000002090","article-title":"Clinical validation of a test for the diagnosis of vaginitis","volume":"130","author":"Gaydos","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R42-20230711","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s10096-019-03480-8","article-title":"Accuracy of the BD MAX vaginal panel in the diagnosis of infectious vaginitis","volume":"38","author":"Aguirre-Quinonero","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R43-20230711","doi-asserted-by":"crossref","first-page":"e00252","DOI":"10.1128\/JCM.00252-18","article-title":"Diagnostic performance of a molecular test versus clinician assessment of vaginitis","volume":"56","author":"Schwebke","year":"2018","journal-title":"J Clin Microbiol"},{"key":"R44-20230711","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.olq.0000218869.52753.c7","article-title":"The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology","volume":"33","author":"Cherpes","year":"2006","journal-title":"Sex Transm Dis"},{"key":"R45-20230711","doi-asserted-by":"crossref","first-page":"517.e1","DOI":"10.1016\/j.ajog.2007.02.048","article-title":"A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases","volume":"196","author":"Schwebke","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R46-20230711","first-page":"443","article-title":"Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream","volume":"41","author":"Ferris","year":"1995","journal-title":"J Fam Pract"},{"key":"R47-20230711","first-page":"889","article-title":"Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy","volume":"45","author":"Hanson","year":"2000","journal-title":"J Reprod Med"},{"key":"R48-20230711","first-page":"256","article-title":"Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial","volume":"96","author":"Paavonen","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R49-20230711","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.AOG.0000275282.60506.3d","article-title":"Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: a randomized controlled trial","volume":"110","author":"Livengood","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R50-20230711","doi-asserted-by":"crossref","first-page":"678.e1","DOI":"10.1016\/j.ajog.2017.08.017","article-title":"A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis [published erratum appears in Am J Obstet Gynecol 2018;219:110]","volume":"217","author":"Schwebke","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R51-20230711","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejogrb.2019.05.013","article-title":"Efficacy and safety of single dose of oral secnidazole 2 g in treatment of bacterial vaginosis: a systematic review and meta-analysis","volume":"238","author":"Elghazaly","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R54-20230711","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/sti.2002.002733","article-title":"Managing recurrent bacterial vaginosis","volume":"80","author":"Wilson","year":"2004","journal-title":"Sex Transm Infect"},{"key":"R55-20230711","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1086\/503780","article-title":"High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence","volume":"193","author":"Bradshaw","year":"2006","journal-title":"J Infect Dis"},{"key":"R56-20230711","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.ajog.2005.11.041","article-title":"Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis","volume":"194","author":"Sobel","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R57-20230711","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/OLQ.0b013e3181b08456","article-title":"Boric acid addition to suppressive antimicrobial therapy for recurrent bacterial vaginosis","volume":"36","author":"Reichman","year":"2009","journal-title":"Sex Transm Dis"},{"key":"R58-20230711","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/OLQ.0b013e318203e3ce","article-title":"Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations","volume":"38","author":"Roth","year":"2011","journal-title":"Sex Transm Dis"},{"key":"R59-20230711","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/jama.1988.03720080057028","article-title":"Diagnosis of trichomoniasis. Comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens","volume":"259","author":"Krieger","year":"1988","journal-title":"JAMA"},{"key":"R60-20230711","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/clinids\/23.5.1075","article-title":"Clinical and microbiological correlates of vaginal trichomoniasis during pregnancy. The Vaginal Infections and Prematurity Study Group","volume":"23","author":"Pastorek","year":"1996","journal-title":"Clin Infect Dis"},{"key":"R61-20230711","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1128\/JCM.02367-10","article-title":"Comparison of Aptima Trichomonas vaginalis transcription-mediated amplification assay and BD affirm VPIII for detection of T. vaginalis in symptomatic women: performance parameters and epidemiological implications","volume":"49","author":"Andrea","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R62-20230711","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1128\/JCM.01291-11","article-title":"Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial","volume":"49","author":"Schwebke","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R63-20230711","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1086\/518851","article-title":"Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women","volume":"45","author":"Huppert","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R64-20230711","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jpag.2010.03.004","article-title":"Screening for Trichomonas vaginalis in high-risk adolescent females with a new transcription-mediated nucleic acid amplification test (NAAT): associations with ethnicity, symptoms, and prior and current STIs","volume":"23","author":"Hollman","year":"2010","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R65-20230711","doi-asserted-by":"crossref","first-page":"188.e1","DOI":"10.1016\/j.ajog.2008.10.005","article-title":"Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women","volume":"200","author":"Nye","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"R66-20230711","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1128\/JCM.43.2.684-687.2005","article-title":"Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens","volume":"43","author":"Huppert","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R67-20230711","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1128\/JCM.38.10.3585-3588.2000","article-title":"Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR","volume":"38","author":"Lawing","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R68-20230711","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ajog.2003.08.023","article-title":"Trichomoniasis: under control or undercontrolled?","volume":"190","author":"Soper","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R69-20230711","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S1473-3099(18)30423-7","article-title":"Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial","volume":"18","author":"Kissinger","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"R71-20230711","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/OLQ.0000000000000537","article-title":"Single-dose compared with multidose metronidazole for the treatment of trichomoniasis in women: a meta-analysis","volume":"44","author":"Howe","year":"2017","journal-title":"Sex Transm Dis"},{"key":"R72-20230711","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2500\/ar.2014.5.0080","article-title":"Modified oral metronidazole desensitization protocol","volume":"5","author":"Gendelman","year":"2014","journal-title":"Allergy Rhinol (Providence)"},{"key":"R73-20230711","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3201\/eid1806.111590","article-title":"Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009-2010","volume":"18","author":"Kirkcaldy","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"R74-20230711","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1128\/AAC.00814-06","article-title":"Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole","volume":"50","author":"Schwebke","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"R75-20230711","first-page":"545","article-title":"Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic","volume":"46","author":"Schmid","year":"2001","journal-title":"J Reprod Med"},{"key":"R76-20230711","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1086\/323034","article-title":"Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis","volume":"33","author":"Sobel","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R77-20230711","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00007435-200406000-00004","article-title":"Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients","volume":"31","author":"Hager","year":"2004","journal-title":"Sex Transm Dis"},{"key":"R78-20230711","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1586\/14787210.2014.887440","article-title":"Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations","volume":"12","author":"Sena","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R79-20230711","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0002-9378(95)90347-X","article-title":"Chronic fungal vaginitis: the value of cultures","volume":"173","author":"Nyirjesy","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"R80-20230711","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/LGT.0000000000000126","article-title":"Non-albicans candida vulvovaginitis: treatment experience at a tertiary care vaginitis center","volume":"20","author":"Powell","year":"2016","journal-title":"J Low Genit Tract Dis"},{"key":"R81-20230711","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00019048-200009020-00007","article-title":"Difficulties in the diagnosis of candida vaginitis","volume":"9","author":"Ledger","year":"2000","journal-title":"Infect Dis Clin Pract"},{"key":"R82-20230711","first-page":"419","article-title":"Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis","volume":"99","author":"Ferris","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R83-20230711","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0140-6736(07)60917-9","article-title":"Vulvovaginal candidosis","volume":"369","author":"Sobel","year":"2007","journal-title":"Lancet"},{"key":"R84-20230711","first-page":"757","article-title":"Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm","volume":"92","author":"Eckert","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R85-20230711","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R86-20230711","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11908-013-0325-5","article-title":"Mixed vaginitis-more than coinfection and with therapeutic implications","volume":"15","author":"Sobel","year":"2013","journal-title":"Curr Infect Dis Rep"},{"key":"R88-20230711","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0002-9378(95)91490-0","article-title":"Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Fluconazole Vaginitis Study Group","volume":"172","author":"Sobel","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"R89-20230711","first-page":"595","article-title":"Women's use of over-the-counter antifungal medications for gynecologic symptoms","volume":"42","author":"Ferris","year":"1996","journal-title":"J Fam Pract"},{"key":"R90-20230711","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/AOG.0b013e31827307b2","article-title":"Fluconazole-resistant Candida albicans vulvovaginitis","volume":"120","author":"Marchaim","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R91-20230711","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajog.2015.06.067","article-title":"Recurrent vulvovaginal candidiasis","volume":"214","author":"Sobel","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R92-20230711","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/sextrans-2012-050669","article-title":"How to treat persistent vaginal yeast infection due to species other than Candida albicans","volume":"89","author":"Davies","year":"2013","journal-title":"Sex Transm Infect"},{"key":"R93-20230711","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/1098-0997(2000)8:5<240::AID-IDOG1026>3.0.CO;2-4","article-title":"Terconazole cream for non-Candida albicans fungal vaginitis: results of a retrospective analysis","volume":"8","author":"Sood","year":"2000","journal-title":"Infect Dis Obstet Gynecol"},{"key":"R94-20230711","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa033114","article-title":"Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis","volume":"351","author":"Sobel","year":"2004","journal-title":"N Engl J Med"},{"key":"R95-20230711","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/14656566.2018.1476490","article-title":"Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species","volume":"19","author":"Sobel","year":"2018","journal-title":"Expert Opin Pharmacother"},{"key":"R96-20230711","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1067\/mob.2001.115116","article-title":"Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole","volume":"185","author":"Sobel","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R97-20230711","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1067\/S0002-9378(03)00726-9","article-title":"Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine","volume":"189","author":"Sobel","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R98-20230711","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1089\/jwh.2010.2708","article-title":"Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence","volume":"20","author":"Iavazzo","year":"2011","journal-title":"J Womens Health (Larchmt)"},{"key":"R99-20230711","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0002-9343(99)00466-0","article-title":"A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis","volume":"108","author":"Wiese","year":"2000","journal-title":"Am J Med"},{"key":"R100-20230711","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/01.OLQ.0000079525.04451.05","article-title":"A comparative evaluation of the Papanicolaou test for the diagnosis of trichomoniasis","volume":"30","author":"Lobo","year":"2003","journal-title":"Sex Transm Dis"},{"key":"R101-20230711","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/01.AOG.0000140687.51048.73","article-title":"Vaginal yeast colonization in nonpregnant women: a longitudinal study","volume":"104","author":"Beigi","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R102-20230711","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1067\/mob.2000.105394","article-title":"The Papanicolaou smear: inadequate screening test for bacterial vaginosis during pregnancy","volume":"182","author":"Greene","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"R103-20230711","first-page":"27799","article-title":"Changes in vaginal microbiota following antimicrobial and probiotic therapy","volume":"26","author":"Macklaim","year":"2015","journal-title":"Microb Ecol Health Dis"},{"key":"R104-20230711","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jac\/dkl246","article-title":"Probiotics for prevention of recurrent vulvovaginal candidiasis: a review","volume":"58","author":"Falagas","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R105-20230711","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/bmj.38210.494977.DE","article-title":"Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial","volume":"329","author":"Pirotta","year":"2004","journal-title":"BMJ"},{"key":"R106-20230711","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.micinf.2006.01.003","article-title":"Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial","volume":"8","author":"Anukam","year":"2006","journal-title":"Microbes Infect"},{"key":"R107-20230711","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejogrb.2012.12.031","article-title":"Efficacy of orally applied probiotic capsules for bacterial vaginosis and other vaginal infections: a double-blind, randomized, placebo-controlled study","volume":"168","author":"Vujic","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R108-20230711","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1179\/joc.2009.21.3.243","article-title":"The role of lactobacillus probiotics in the treatment or prevention of urogenital infections\u2014a systematic review","volume":"21","author":"Abad","year":"2009","journal-title":"J Chemother"},{"key":"R110-20230711","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/OLQ.0b013e31822037e4","article-title":"Resistant trichomoniasis: successful treatment with combination therapy","volume":"38","author":"Nyirjesy","year":"2011","journal-title":"Sex Transm Dis"},{"key":"R111-20230711","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1258\/ijsa.2009.009085","article-title":"Paromomycin treatment of recalcitrant Trichomonas vaginalis","volume":"21","author":"Tayal","year":"2010","journal-title":"Int J STD AIDS"},{"key":"R112-20230711","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1071\/SH11114","article-title":"Symptomatic Trichomonas vaginalis infection in the setting of severe nitroimidazole allergy: successful treatment with boric acid","volume":"9","author":"Muzny","year":"2012","journal-title":"Sex Health"},{"key":"R113-20230711","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1097\/AOG.0000000000002621","article-title":"Expedited partner therapy. ACOG Committee Opinion No. 737. American College of Obstetricians and Gynecologists","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R114-20230711","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/OLQ.0b013e3182631d89","article-title":"Systematic review of randomized trials of treatment of male sexual partners for improved bacteria vaginosis outcomes in women","volume":"39","author":"Mehta","year":"2012","journal-title":"Sex Transm Dis"},{"key":"R115-20230711","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00007435-200105000-00011","article-title":"Preventing adverse sequelae of bacterial vaginosis: a public health program and research agenda. CDC Bacterial Vaginosis Working Group","volume":"28","author":"Koumans","year":"2001","journal-title":"Sex Transm Dis"},{"key":"R116-20230711","first-page":"174","article-title":"The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole","volume":"68","author":"Fong","year":"1992","journal-title":"Genitourin Med"},{"key":"R117-20230711","first-page":"267","article-title":"Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial","volume":"73","author":"Colli","year":"1997","journal-title":"Genitourin Med"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T15:45:53Z","timestamp":1689090353000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003604"}},"subtitle":["ACOG Practice Bulletin, Number 215"],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":112,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003604","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737123910.793579745","asserted-by":"object"}]},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}